Ornella Patrizi
Brescia, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
PD-1+ NK cell subsets in high grade serous ovarian cancer: an indicator of disease severity and a target for combined immune-checkpoint blockade.
Journal: Journal of experimental & clinical cancer research : CR
Published: December 13, 2024
Lack of DOCK8 impairs the primary biologic functions of human NK cells and abrogates CCR7 surface expression in a WASP-independent manner.
Journal: Clinical immunology (Orlando, Fla.)
Published: January 21, 2022
Natural killer cell impairment in ovarian clear cell carcinoma.
Journal: Journal of leukocyte biology
Published: May 14, 2020
The RAC2-PI3K axis regulates human NK cell maturation and function.
Journal: Clinical immunology (Orlando, Fla.)
Published: August 07, 2019
From Natural Killer Cell Receptor Discovery to Characterization of Natural Killer Cell Defects in Primary Immunodeficiencies.
Journal: Frontiers in immunology
Published: May 06, 2019
Strengthening the AntiTumor NK Cell Function for the Treatment of Ovarian Cancer.
Journal: International journal of molecular sciences
Published: January 31, 2019
Response to the Letter to the Editor Regarding "Functional evaluation of natural killer cell cytotoxic activity in NFKB-2 mutated patients".
Journal: Immunology letters
Published: May 09, 2018
CTLA-4 regulates human Natural Killer cell effector functions.
Journal: Clinical immunology (Orlando, Fla.)
Published: March 05, 2018
Corrigendum: Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56bright NKG2A+++ Cells, and Yet Display Increased Degranulation and Higher Perforin Content.
Journal: Frontiers in immunology
Published: September 10, 2017
NFKB1 regulates human NK cell maturation and effector functions.
Journal: Clinical immunology (Orlando, Fla.)
Published: July 08, 2016
Impaired natural killer cell functions in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations.
Journal: The Journal of allergy and clinical immunology
Published: December 21, 2015
Last Updated: 09/26/2026